Chinese pharmaceutical and 3D printing technology firm Triastek has received Investigational New Drug (IND) approval from the US Food and Drug Administration (FDA) for its first 3D printed drug produc…
Triastek raises $15M to accelerate development of 3D printed drugs
Chinese 3D printing technology startup Triastek has raised $15 million in Series A funding to accelerate the research and development of its 3D printed drugs. The funding round was led by fund managem…